CoChat

Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans

Walsh, Sharon, Strain, Eric, Abreu, Mary, Bigelow, George · 2001 · Psychopharmacology

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Abstract

Rationale The availability of the highly selective and specific kappa opioid agonist enadoline provides an opportunity to explore the function of kappa receptors in humans and their potential utility as a target for substance abuse pharmacotherapy development.Objectives The purpose of this study was to characterize the pharmacodynamic effects of enadoline, a selective kappa agonist, and to compare it with butorphanol, a mixed mu/kappa agonist, and hydromorphone, a mu agonist, in humans.Methods Pilot evaluation (n=3) served to establish intramuscular doses of enadoline (20, 40, 80, and 160 microg/70 kg), butorphanol (1.5, 3, 6, and 12 mg/70 kg), and hydromorphone (1.5, 3, and 6 mg/70 kg) of comparable activity. These acute doses were examined under double-blind, placebo-controlled and constrained randomized conditions with a minimum of 72 h between tests in volunteers with polysubstance abuse histories (n=6). Physiological and subject- and observer-rated measures were collected 30 min before and for 4 h after administration.Results Enadoline significantly increased measures of sedation, confusion and dizziness, produced visual distortions and feelings of depersonalization, and increased urinary output. The highest dose (160 microg/70 kg) was not tolerated and led to psychotomimetic effects. Hydromorphone produced prototypic mu opioid effects including respiratory depression, miosis, and euphoria. Butorphanol was most similar to hydromorphone and shared few effects with enadoline.Conclusions These results are discussed with respect to the potential use and safety of kappa agonists for clinical indications.

Overview

Integrity signals

Registry

Crossref · 10.1007/s002130100788

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 269

Metadata

Authors
Walsh, S., Strain, E., Abreu, M., & Bigelow, G.
Affiliations
  • Johns Hopkins University (US)
  • AstraZeneca (United States) (US)
Venue
Psychopharmacology
Published
2001-09-01
Volume
157
Issue
2
Pages
151-162
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W2148208755
Cited by
258
References
51
Citations by year
2026: 7 · 2025: 11 · 2024: 6 · 2023: 5 · 2022: 6 · 2021: 19 · 2020: 9 · 2019: 5 · 2018: 6 · 2017: 7 · 2016: 15 · 2015: 14 · 2014: 6 · 2013: 15 · 2012: 10
FWCI
2.46
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Public Health Service
  • National Institute on Drug Abuse (K05DA000050, K05 DA00050, T32-DA07209, R01 DA10753, R01DA010753, T32DA007209)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Keywords
kappa opioid receptor agonists, butorphanol, hydromorphone, opioid pharmacodynamics, sedation, psychotomimetic effects, respiratory depression, polysubstance abuse, opioid analgesics, drug safety
MeSH terms
Adult, Analgesics, Opioid, Analysis of Variance, Benzofurans, Butorphanol, Hydromorphone, Dose-Response Relationship, Drug, Double-Blind Method, Female, Heroin Dependence, Humans, Male, Middle Aged, Pilot Projects, Pyrrolidines, Receptors, Opioid, kappa, Cross-Over Studies, Neuroprotective Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.